Home › The Wall Street Journal: Actavis set for $20 billion corporate-bond sale
 

Keywords :   


The Wall Street Journal: Actavis set for $20 billion corporate-bond sale

2015-03-02 14:28:45| Biotech - Topix.net

Pharmaceutical company Actavis PLC is expected to sell more than $20 billion in bonds as early as this week, a deal that would rank as the second-largest corporate bond ever and further propel bond sales this year into record territory. Traders expect the bonds to fly off the shelves, with investors globally searching for income-generating investments at a time of low rates on safe government debt.

Tags: set sale street journal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »